Atlas Trials

Tdap Vaccine Safety for Plasma Donors

Clinical trial NCT04142983 · COMPLETED

Trial details

NCT number
NCT04142983
Sponsor
GCAM Inc.
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Tetanus
Start date
2020-02-03
Primary completion
2021-11-03
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.